APG Asset Management US’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-119,114
Closed -$3.24M 147
2025
Q3
$3.24M Buy
119,114
+2,011
+2% +$49.6K 0.02% 88
2025
Q2
$2.93M Hold
117,103
0.02% 86
2025
Q1
$2.87M Hold
117,103
0.02% 88
2024
Q4
$3.11M Buy
117,103
+83,554
+249% +$2.27M 0.02% 79
2024
Q3
$962K Sell
33,549
-371,718
-92% -$10.8M 0.01% 120
2024
Q2
$11.4M Sell
405,267
-101,021
-20% -$2.78M 0.07% 119
2024
Q1
$14M Sell
506,288
-198,168
-28% -$5.5M 0.08% 107
2023
Q4
$20.3M Buy
+704,456
New +$21.3M 0.12% 68

Other funds holding PFE

APG Asset Management US's PFE Position: Q4 2025 in Review

APG Asset Management US sold out of Pfizer (PFE) in Q4 2025, closing a stake of 119,114 shares — an estimated $3.24M sold.

APG Asset Management US first reported a position in PFE in Q4 2023 and held it in 8 quarters. The position peaked at $20.3M in Q4 2023. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • APG Asset Management US reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 119,114 Pfizer shares in Q4 2025, an estimated $3.24M.
  • APG Asset Management US first reported a position in Pfizer in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Pfizer position peaked at $20.3M in Q4 2023.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.